← Back to blog
beginners guide

How to Start Peptide Therapy: A Step-by-Step Guide

By TelosRX Editorial Team July 17, 2026
Male athlete stretching on red running track

Starting peptide therapy requires a provider-approved evaluation, a matched protocol, and proper administration technique. At TelosRX, the entire process is completed asynchronously online — no in-person visits required — subject to medical approval by a licensed provider.

Peptide therapy has become one of the fastest-growing areas of interest in performance optimization and healthy aging research. This guide walks through each step of the process — from understanding what peptides are to monitoring your response over time — using an asynchronous telehealth framework.

Step 1: Understand What Peptide Therapy Is

Peptides are short chains of amino acids that act as biological signaling molecules. Unlike full proteins, peptides are small enough to cross cell membranes and bind to specific receptors, where they modulate processes such as hormone secretion, tissue repair, immune activity, and cellular metabolism.

Research peptides used in clinical and compounding practice are typically synthetic analogs of naturally occurring peptides. They are studied for their ability to amplify or restore specific biological signals that decline with age, injury, or physiological stress.

Compounded peptides are not FDA-approved. They are prepared under federal compounding regulations at licensed pharmacies and dispensed only upon prescription from a licensed provider. The FDA compounding resource page outlines the federal regulatory framework that governs these preparations.

Step 2: Identify Your Goal

Before beginning any evaluation, it helps to have a clear sense of what you are hoping to address. Different peptides have been studied for different physiological targets. The table below summarizes commonly explored goal categories:

Goal Commonly Studied Peptide Classes Proposed Mechanism
Physical recovery BPC-157, TB-500 (Thymosin Beta-4 analog) Tissue repair signaling, angiogenesis
Growth hormone optimization CJC-1295, Ipamorelin, Sermorelin GHRH/ghrelin receptor stimulation
Cognitive support Semax, Selank BDNF modulation, neuroprotection (preclinical)
Skin health GHK-Cu Collagen synthesis, wound healing
Metabolic longevity MOTS-c, Humanin Mitochondrial signaling, insulin sensitivity

This table reflects research categories, not clinical recommendations. Your specific protocol is determined by a licensed provider, subject to medical approval, based on your individual health profile.

Step 3: Complete an Asynchronous Health Evaluation

At TelosRX, your evaluation is completed entirely online on your own schedule. The intake process collects:

  • Medical history: current conditions, prior surgeries, medications, and allergies
  • A goal and symptom questionnaire aligned to your primary interest area
  • Recent lab work, if available — growth hormone panels, metabolic panels, or hormone profiles may be relevant depending on your goals
  • Lifestyle context: sleep patterns, exercise frequency, and nutritional approach

You do not need to schedule a call or appear on video. Your intake is reviewed asynchronously by a licensed provider who evaluates whether peptide therapy is appropriate for you and which protocol, if any, aligns with your profile.

See the TelosRX BPC-157 Patient Guide for an example of what a condition-specific evaluation covers.

Step 4: Receive a Protocol Recommendation

If your provider determines peptide therapy is appropriate — subject to medical approval by a licensed provider — you will receive a protocol specifying:

  • The peptide or peptides selected for your goals
  • The dose, typically expressed in micrograms or milligrams per injection
  • The frequency: daily, five days on/two days off, or cycling protocols
  • The duration of the initial protocol, commonly 8–16 weeks
  • Monitoring checkpoints and any recommended follow-up labs

Not every evaluation results in a prescription. Provider approval is required, and approval is not guaranteed. If the provider determines peptide therapy is not appropriate for you, alternative recommendations may be offered.

Step 5: Learn the Administration Method

Most research peptides are dispensed as lyophilized (freeze-dried) powder requiring reconstitution with bacteriostatic water before injection. Your kit includes detailed reconstitution and injection instructions.

Standard administration is subcutaneous — a short (5mm–8mm) insulin-style needle inserted at a 45-degree angle into abdominal or thigh fat. This technique carries minimal discomfort for most people and does not require medical training to perform safely once instructed.

Injection sites should be rotated to prevent localized irritation. Store reconstituted peptides refrigerated at 2–8°C and discard according to the expiration guidance provided with your shipment.

Research on growth hormone secretagogue peptides, including CJC-1295 and Ipamorelin, is summarized in a PubMed review of GH peptide protocols. For detailed protocol context, see the TelosRX CJC-1295/Ipamorelin Research guide.

Step 6: Start at the Lowest Effective Dose

Peptide protocols almost universally begin at the lower end of the studied dose range, subject to medical approval by a licensed provider. Starting low:

  • Allows you to assess individual tolerance and identify any early adverse reactions
  • Reduces the risk of receptor desensitization that can occur at higher doses
  • Establishes a baseline from which your provider can titrate upward if indicated

Do not escalate your dose independently. All dose adjustments must be reviewed and approved by your licensed provider through your patient portal. This is a non-negotiable safety principle for compounded medications that are not FDA-approved.

Step 7: Monitor Your Response

Track your response systematically so your provider can evaluate progress at follow-up intervals. Relevant monitoring points vary by peptide class:

  • Recovery peptides (BPC-157, TB-500): Pain scores, range of motion, and functional performance benchmarks
  • Growth hormone peptides (CJC-1295/Ipamorelin): Sleep quality, energy levels, body composition changes, and IGF-1 levels via lab if ordered
  • Metabolic peptides (MOTS-c): Fasting glucose, subjective energy, and exercise capacity

Report any unexpected symptoms — redness at the injection site, unusual fatigue, headaches, or hormonal changes — promptly through your patient portal. A comprehensive overview of tissue-repair peptide research is available in the TelosRX TB-500 Research guide.

Frequently Asked Questions

What is peptide therapy used for?

Peptide therapy is explored for goals including physical recovery, growth hormone optimization, cognitive support, skin health, and healthy aging. The appropriateness of any specific peptide is determined by a licensed provider based on individual evaluation.

Are compounded peptides FDA-approved?

Compounded peptides are not FDA-approved. They are prepared under federal compounding regulations at licensed compounding pharmacies. A licensed provider must evaluate and approve your protocol before any compounded peptide is dispensed.

How do I know which peptide is right for me?

A licensed provider determines which peptide, if any, is appropriate based on your health history, goals, and any relevant lab work. Self-selecting peptides without provider evaluation is not recommended.

How are peptides typically administered?

Most research peptides are administered via subcutaneous injection using small insulin-style needles. Some are available as oral or nasal formulations. Your provider will specify the administration method in your protocol.

How long does it take to see results from peptide therapy?

Timelines vary by peptide and individual. Growth hormone peptides typically require 3 to 6 months of consistent use before significant changes in body composition are observed. Recovery-focused peptides may produce noticeable effects within weeks for some individuals.

Can I start peptide therapy without a prescription?

No. Compounded peptides require a prescription from a licensed provider. Starting peptide therapy requires completing a health evaluation, receiving a protocol recommendation, and obtaining provider approval — all of which are required before any medication is dispensed.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX